Organized by the Instituto RIA with the support of Mexico, Acción Técnica Social, Elementa DDHH, the Frederich Ebert Stiftung Institute, the International Drug Policy Consortium and Kykeon Analytics Tuesday 19th March 2024 – 08:10-09:00, MOE100 Panellists: Paula Aguirre – Elementa DDHH Dalel Perez – Instituto RIA Nuria Calzada – Kykeon Analytics Johan Wicklen – Reporter …
Informal Dialogue with WHO
SSDP Australia: How is the World Health Organisation facilitating meaningful inclusion of people who use drugs in the design and implementation of policies and strategies around existing and emerging pharmacotherapies at the global level? WHO: The principle of involving affected groups in the development of guidance is strong. To develop WHO guidelines on managing health …
Side event: Exploring responsible legal regulation to promote human rights, health, and security in Europe
Organized by Foreningen for Human Narkotikapolitikk with the support of Czechia, Germany, the Office of the High Commissioner for Human Rights, Amnesty International, the International Drug Policy Consortium and the International Network of People who Use Drugs Marie Nougier, IDPC: IDPC is a global network of NOGs that promote drug policies that advance social justice …
Side Event: From synthetic drug threats to synthetic drug realities: Examining the role of global drug policies and charting a way forward
FROM SYNTHETIC DRUG THREATS TO SYNTHETIC DRUG REALITIES: EXAMINING THE ROLE OF GLOBAL DRUG POLICIES AND CHARTING A WAY FORWARD Organized by the Washington Office on Latin America with the support of the Canadian Association of People who Use Drugs, the Canadian Drug Policy Coalition, the Centre on Drug Policy Evaluation, the Drug Policy Alliance, …
Item 5. Implementation of the international drug control treaties (Tuesday morning)
Chair: We will consider scheduling recommendations by WHO and INCB. CND Secretariat: Recalls the substances and scheduling recommendations. Chair: Explains process to schedule substances under 1961, 1971 and 1988 conventions. Butonitazene WHO: Butonitazene, or butoxynitazene, is a benzimidazole-derived synthetic opioid not currently under international control and lacking recognized therapeutic use. It appears as a crystalline …
Side event: Economic, social and cultural rights in drug policy making: The relevance of an upcoming CESCR General Comment on drugs
Side event organised by Amnesty International with the support of Colombia, Czechia, Mexico, the Corporación Centro de Estudios de Derecho, Justicia y Sociedad, Elementa Derechos Humanos, the Eurasian Harm Reduction Association, the Friedrich Ebert Foundation, the Helsinki Foundation for Human Rights, the International Drug Policy Consortium, the International Harm Reduction Association, the International Network of …